Keyphrases
Prostate Cancer
100%
Shock Wave Lithotripsy
94%
Retrograde Intrarenal Surgery
63%
Prostate Cancer Patients
47%
Renal Stone
37%
Androgen Deprivation Therapy
36%
Radical Prostatectomy
36%
Postoperative Day
34%
Urethral Leiomyoma
31%
Female Urethra
31%
Low Magnesium
31%
Urological Pathology
31%
Gleason Upgrading
31%
Gleason Grading System
31%
Metabolic Markers
31%
Factors Predicting
31%
Salvage Radiotherapy
31%
Extracorporeal Shock Wave Lithotripsy
31%
Health-related Quality of Life
31%
Cancer Inpatients
31%
Lymphocyte Subsets
31%
Fournier's Gangrene
31%
Bioelectrical Impedance Analysis
31%
Fournier Gangrene Severity Index
31%
Randomized pilot Trial
31%
Magnesium Level
31%
Multicentric
31%
Leiomyoma
31%
Renal Function
31%
Prognostic Factors
31%
Oncological Outcomes
31%
C-level
31%
International Society
31%
Prospective Randomized Trial
31%
Cystatin C (Cys C)
31%
Upper Ureteral Stones
31%
Surgery Groups
30%
Urinary Tract Infection
26%
CD3+
23%
Pathological Stage
23%
CD4+
23%
Prostate-specific Antigen
19%
Muscle Origin
15%
Acute Urinary Retention
15%
Treatment Choice
15%
Surgical Removal
15%
Charlson Comorbidity Index
15%
Tumor
15%
Dysuria
15%
Blood Samples
15%
Medicine and Dentistry
Prostate Cancer
94%
Lithotripsy
94%
Shock Wave
91%
Kidney Stone
37%
Gleason Score
36%
Prostatectomy
34%
Angioleiomyoma
31%
Kidney Function
31%
Radiation Therapy
31%
Magnesium
31%
Cystatin C
31%
Fournier Gangrene
31%
Ureter Stone
31%
Extracorporeal Shock Wave Lithotripsy
31%
Lymphocyte
31%
Prostate Specific Antigen
29%
Neoplasm
26%
Malignant Neoplasm
22%
Urinary Tract Infection
19%
CD3 Antigen
15%
Charlson Comorbidity Index
14%
Biochemical Recurrence
12%
Surgical Margin
12%
Diseases
11%
Benign Tumor
10%
Strangury
10%
Smooth Muscle
10%
Urinary Retention
10%
Hematuria
10%
Visual Analog Scale
9%
Radical Retropubic Prostatectomy
9%
Cancer Specific Survival
9%
Overall Survival
9%
CD3+ T Lymphocyte
7%
CD4+ T Lymphocyte
7%
CD8 Antigen
7%
T Lymphocyte
7%
Natural Killer Cell
7%
B Lymphocyte
7%
Immune System
7%
Immune Function
7%
Adjuvant Therapy
7%
Survival Rate
7%
Biochemical Recurrence Free Survival
7%
Body Mass Index
7%
Immunoassay
6%
Kidney Injury
6%
Infection Complication
6%
Tumor Biopsy
6%
Renal Colic
6%